Allogene Therapeutics

Logo GlobeNewswire
TechnologyPress Release2023-03-23 14:00:00
London, UK, March 23, 2023 (GLOBE NEWSWIRE) -- ALLIN, a revolutionary project that leverages artificial intelligence to provide innovative solutions for...

Logo EIN Presswire
Drugs For Hormonal Replacement Therapy Global Market Report 2023 - Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company's Drugs...

Logo Nasdaq
Business / FinanceBy Validea2023-03-23 14:06:11
Below is Validea's guru fundamental report for ALLSTATE CORP ( ALL ). Of the 22 guru strategies we follow, ALL rates highest using our Multi-Factor Investor...

Logo EIN Presswire
Autoimmune Disease Therapeutics Market Growth PORTLAND, OREGON, UNITED STATES, March 23, 2023 / EINPresswire.com / -- Autoimmune diseases occur when the...

Logo GlobeNewswire
SciencePress Release2023-03-23 10:30:00
Progress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive Sorbitol Reduction Data from the Ongoing Phase 3 INSPIRE Trial in...

Logo GlobeNewswire
SciencePress Release2023-03-23 21:00:00
Daix (France), Long Island City (New York, United States), March 23, 2023 Inventiva (Euronext Paris and Nasdaq: IVA) (the Company), a clinical-stage...

Logo Benzinga
Business / FinanceBy Vandana Singh2023-03-23 14:35:33
The FDA approved Cidara Therapeutics Inc's CDTX antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive candidiasis in...

Logo GlobeNewswire
SciencePress Release2023-03-23 11:00:00
Validive Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next Week Camsirubicin Phase 1b Dose-Escalation Trial Now Enrolling 5th...

Logo GlobeNewswire
SciencePress Release2023-03-23 11:00:00
TORONTO, March 23, 2023 (GLOBE NEWSWIRE) -- Today, Arch Biopartners Inc., (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage...

Logo PR Newswire
HealthPress Release2023-03-23 12:33:00
WASHINGTON, March 23, 2023 /PRNewswire/ -- In observance of National Adverse Drug Awareness Day on March 24, the American Society of Pharmacovigilance (ASP)...

Logo CNBC
HealthBy Annika Kim Constantino2023-03-22 22:55:25
Key Points The FDA's independent panel of advisors voted against the effectiveness of Biogen's investigational ALS drug for a rare and aggressive form of the...

Logo GlobeNewswire
SciencePress Release2023-03-23 12:00:00
Oral Presentation to Feature Results from ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy Patients Results from Phase 3 LYNX-1 Trial of Nyxol in Dim...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:44:00
APTIVATE Expansion Trial of Tuspetinib as Single Agent in Relapsed/Refractory AML Patients is Up and Running; Initiated Enrollment of Combination Treatment...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 06:00:00
Sanofi collaboration for Natural Killer cell engager therapeutics expanded to B7-H3 ANKET program and two additional targets, with 25 million payment...

Logo CNBC
HealthBy Annika Kim Constantino2023-03-23 18:31:20
Key Points Shares of drugmakers Sanofi and Regeneron both jumped more than 6% on Thursday after they released data on a jointly developed drug that shows...

Logo PR Newswire
HealthPress Release2023-03-23 12:03:00
DEERFIELD BEACH, Fla., March 23, 2023 /PRNewswire/ -- All Star Healthcare Solutions ®, a full-service healthcare staffing firm specializing in locum tenens...

Logo EIN Presswire
AU409 trial to be conducted by Dr. Anthony El-Khoueiry at the USC Norris Comprehensive Cancer Center, University of Southern California PALO ALTO,...

Logo PR Newswire
HealthPress Release2023-03-23 12:39:00
­­­­­ Researchers have unraveled key physiological mechanisms to pave the way for the discovery of novel therapeutics XI'AN, China, March 23, 2023...

Logo GlobeNewswire
EconomyPress Release2023-03-23 17:30:00
The Global mRNA Therapeutics Market Size was valued at USD 33.60 Billion in 2021 and the worldwide mRNA therapeutics market size is expected to reach USD...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-22 23:30:00
Presentations Explore ARIA with the Use of Antiplatelets or Anticoagulants and Isolated ARIA-H in Patients from Eisai's Lecanemab Phase 3 Confirmatory...